Search

Your search keyword '"CoMSIA"' showing total 1,321 results

Search Constraints

Start Over You searched for: Descriptor "CoMSIA" Remove constraint Descriptor: "CoMSIA"
1,321 results on '"CoMSIA"'

Search Results

251. Docking-based 3D-QSAR study of pyridyl aminothiazole derivatives as checkpoint kinase 1 inhibitors.

252. Collateral sensitivity of resistant MRP1-overexpressing cells to flavonoids and derivatives through GSH efflux.

253. Investigations and design of pyridine-2-carboxylic acid thiazol-2-ylamide analogs as methionine aminopeptidase inhibitors using 3D-QSAR and molecular docking.

254. Prediction of binding affinities of PCDDs, PCDFs and PCBs using docking-based Comparative Molecular Similarity Indices Analysis.

255. Docking and Quantitative Structure Activity Relationship studies of Acyl Guanidines as β-Secretase (BACE1) Inhibitor.

256. 3D-QSAR studies on the toxicity of substituted benzenes to Tetrahymena pyriformis: CoMFA, CoMSIA and VolSurf approaches.

257. 3D-QSAR study on VEGFR kinase inhibition of aminopyrazolopyridine urea derivatives by CoMFA and CoMSIA.

258. Predictive 3D-QSAR and HQSAR model generation of isocitrate lyase (ICL) inhibitors by various alignment methods combined with docking study.

259. Structural findings of quinolone carboxylic acids in cytotoxic, antiviral, and anti-HIV-1 integrase activity through validated comparative molecular modeling studies.

260. 3D-QSAR study using CoMFA and CoMSIA methods for a series of histone H3 phosphorylation inhibitors.

261. 3D QSAR study of 4 H-chromen-1,2,3,4-tetrahydropyrimidine-5-carboxylate derivatives as potential anti-mycobacterial agents.

262. Studies on the inhibitory models of pyrazoline derivatives as EGFR kinase inhibitors by 3D-QSAR and molecular docking.

263. Molecular docking and 3D-QSAR studies on the MAPKAP-K2 inhibitors.

264. Design of novel focal adhesion kinase inhibitors using 3D-QSAR and molecular docking.

265. QSAR studies on diclofenac analogues as potent cyclooxygenase inhibitors using CoMFA and CoMSIA.

266. Molecular docking and 3D-QSAR of 16α,17α-cycloalkanoprogesterone derivatives as ligands of the progesterone receptor.

267. Three-dimensional quantitative structure–activity relationship study on antioxidant capacity of curcumin analogues.

268. Synthesis and 3D-QSAR study of 1,4-dihydropyridine derivatives as MDR cancer reverters.

269. Drug discovery studies on quinoline-based derivatives as potential antimalarial agents.

270. 3D-QSAR and molecular docking studies of amino-pyrimidine derivatives as PknB inhibitors.

271. 2D and 3D-QSAR/CoMSIA Comparative Study On a Series of Thiazole Derivatives as SDHI Inhibitors

272. Quantitative studies on structure–ORAC relationships of anthocyanins from eggplant and radish using 3D-QSAR.

273. Study on the antagonists for the orphan G protein-coupled receptor GPR55 by quantitative structure–activity relationship.

274. Design, synthesis, pharmacological evaluation and in silico ADMET prediction of novel substituted benzimidazole derivatives as angiotensin II–AT 1 receptor antagonists based on predictive 3D QSAR models.

275. 3D-QSAR analysis of anti-cancer agents by CoMFA and CoMSIA.

276. 3D-QSAR study on 2,3-dihydroimidazo[4,5]-pyridin-2-one derivatives with a meta substitution pattern as BRAF inhibitors.

277. 3D-QSAR studies of chromone derivatives as iron-chelating agent.

278. Design of novel anaplastic lymphoma kinase (ALK) inhibitors based on predictive 3D QSAR models using different alignment strategies.

279. Receptor and ligand-based 3D-QSAR study on a series of pyrazines/pyrrolidylquinazolines as inhibitors of PDE10A enzyme.

280. 3D-QSAR study of adamantyl N-benzylbenzamides as melanogenesis inhibitors.

281. Design, synthesis, molecular docking and 3D-QSAR studies of potent inhibitors of enoyl-acyl carrier protein reductase as potential antimycobacterial agents.

282. 3D CoMFA, CoMSIA, topomer CoMFA and HQSAR studies on aromatic acid esters for carbonic anhydrase inhibitory activity.

283. 3D-QSAR Studies of Polyazaheterocyclic Ligands Used in Lanthanide and Actinide Extraction Processes.

284. Design, Synthesis, and Biological Evaluation of Novel Thiazolidinone-Containing Quinoxaline-1,4-di-N-oxides as Antimycobacterial and Antifungal Agents

285. Theoretical Exploring Selective-Binding Mechanisms of JAK3 by 3D-QSAR, Molecular Dynamics Simulation and Free Energy Calculation

286. Combined 3D-QSAR Modeling and Molecular Docking Study on metronidazole-triazole-styryl hybrids as antiamoebic activity

287. 3D-QSAR and docking studies of 3-Pyridine heterocyclic derivatives as potent PI3K/mTOR inhibitors.

288. Synthesis, structure analysis, antitumor evaluation and 3D-QSAR studies of 3,6-disubstituted-dihydro-1,2,4,5-tetrazine derivatives.

289. Exploring structural requirements of aurone derivatives as antimalarials by validated DFT-based QSAR, HQSAR, and COMFA-COMSIA approach.

290. 3D-QSAR studies on the biological activity of juvenile hormone mimetic compounds for Culex pipiens Larvae.

291. Study on the activity of non-purine xanthine oxidase inhibitor by 3D-QSAR modeling and molecular docking.

292. Synthesis, Antibacterial Activities, and 3 D- QSAR of Sulfone Derivatives Containing 1, 3, 4-Oxadiazole Moiety.

293. 3D-QSAR analysis of the interactions of flavonoids with human organic cation transporter 2.

294. In silico exploration of hydroxylated polychlorinated biphenyls as estrogen receptor β ligands by 3D-QSAR, molecular docking and molecular dynamics simulations.

295. In silico multiscale drug design to discover key structural features of potential JAK2 inhibitors.

297. In silico study directed towards identification of the key structural features of GyrB inhibitors targeting MTB DNA gyrase:HQSAR, CoMSIA and molecular dynamics simulations

298. Studies on molecular mechanism between SHP2 and pyridine derivatives by 3D-QSAR, molecular docking and MD simulations

299. In silico design of novel PIN1 inhibitors by combined of 3D-QSAR, molecular docking, molecular dynamic simulation and ADMET studies.

300. Structural insights on 2-phenylquinazolin-4-one derivatives as tankyrase inhibitors through CoMFA, CoMSIA, topomer CoMFA and HQSAR studies.

Catalog

Books, media, physical & digital resources